Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Depiwhite
- Development stage
- Unknown
- Lead developer
- Laboratoire Dermatologique ACM
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Depiwhite is a range of dermatological skin-lightening products developed by Laboratoire Dermatologique ACM, primarily indicated for the treatment of hyperpigmentation disorders such as melasma, liver spots, and post-inflammatory hyperpigmentation. The formulations typically utilize a combination of active ingredients including kojic acid, vitamin C (ascorbyl glucoside), niacinamide, and plant-derived extracts to inhibit tyrosinase activity and melanin transfer. Unlike traditional treatments like hydroquinone, Depiwhite is marketed as a cosmetic or cosmeceutical alternative with a focus on high dermatological tolerance and efficacy in reducing the intensity of brown spots and evening skin tone. Clinical studies have evaluated its performance against 4% hydroquinone, demonstrating significant improvements in the Modified Melasma Area and Severity Index (mMASI) with superior skin tolerability.
- Brand names
- DepiwhiteDepiwhite SerumDepiwhite MDepiwhite Advanced
- Other names
- ACM Depiwhite
02
Targets
TYR (Tyrosinase)
Beyond the preview
Go deeper on Depiwhite.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Depiwhite.